Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study

被引：0
|
作者：
Amabile, Simone [1 ]
Tonella, Luca [1 ]
Rubatto, Marco [1 ]
Argenziano, Giuseppe [2 ]
Babino, Graziella [2 ]
Frascione, Pasquale [3 ]
Dika, Emi [4 ,5 ]
Giacomelli, Luca [6 ]
Parodi, Aurora [7 ]
Quaglino, Pietro [1 ]
机构：
[1] Univ Turin, Dermatol Clin, Sch Med, Turin, Italy
[2] Univ Campania, Dermatol Unit, Naples, Italy
[3] Dermatol Hosp San Gallicano, Oncol Dermatol & Skin Tumor Prevent Unit, Rome, Italy
[4] IRCCS Azienda Osped Univ Bologna, Dermatol, Bologna, Italy
[5] Univ Bologna, Dermatol, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[6] Polistudium SRL, Milan, Italy
[7] Univ Genoa, Dermatol Clin, Genoa, Italy
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2022年 / 32卷 / 01期
关键词：
D O I：
10.1684/ejd.2022.4198
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：126 / 127
页数：2
相关论文
共 50 条
  • [21] BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors
    Mandala, Mario
    Palmieri, Giuseppe
    Ludovini, Vienna
    Baglivo, Sara
    Marasciulo, Francesca
    Castiglione, Francesca
    Gili, Alessio
    Abate, Simona Osella
    Rubatto, Marco
    Senetta, Rebecca
    Avallone, Gianluca
    Ribero, Simone
    Romano, Luca
    Pimpinelli, Nicola
    de Giorgi, Vincenzo
    Roila, Fausto
    Pisano, Marina
    Casula, Milena
    Manca, Antonella
    Sini, Maria Cristina
    Massi, Daniela
    Quaglino, Pietro
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : 1991 - 1998
  • [22] Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
    Ramondetta, Alice
    Ribero, Simone
    Conti, Luca
    Fava, Paolo
    Marra, Elene
    Broganelli, Paolo
    Caliendo, Virginia
    Picciotto, Franco
    Guida, Michele
    Fierro, Maria Teresa
    Quaglino, Pietro
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [23] Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors
    Ramel, Eloise
    Prey, Sorilla
    Dutriaux, Caroline
    Gerard, Emilie
    Pham-Ledard, Anne
    Beylot-Barry, Marie
    Kostine, Marie
    EUROPEAN JOURNAL OF CANCER, 2024, 197
  • [24] Tumor-free osteosclerotic lesions in patients treated for metastatic melanoma using BRAF inhibitors
    Bottlaender, Lea
    Perier-Muzet, Marie
    Lapras, Veronique
    Thomas, Luc
    Dalle, Stephane
    MELANOMA RESEARCH, 2017, 27 (01) : 68 - 71
  • [25] Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients
    Vanneste, L.
    Wolter, P.
    Van den Oord, J. J.
    Stas, M.
    Garmyn, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (01) : 61 - 68
  • [26] Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
    Gavric, Ana Ursula
    Ocvirk, Janja
    Mekjavic, Polona Jaki
    RADIOLOGY AND ONCOLOGY, 2018, 52 (02) : 213 - 219
  • [27] High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors
    Teterycz, Pawel
    Jagodzinska-Mucha, Paulina
    Cybulska-Stopa, Bozena
    Mariuk-Jarema, Anna
    Kozak, Katarzyna
    Kosela-Paterczyk, Hanna
    Czarnecka, Anna M.
    Rajczykowski, Marcin
    Dziura, Robert
    Galus, Lukasz
    Mackiewicz, Jacek
    Switaj, Tomasz
    Klimczak, Anna
    Falkowski, Slawomir
    Suwinski, Rafal
    Ziobro, Marek
    Lugowska, Iwona
    Rutkowski, Piotr
    MELANOMA RESEARCH, 2018, 28 (05) : 435 - 441
  • [28] Outcomes of Patients With Metastatic Melanoma Treated With Immunotherapy Prior to or After BRAF Inhibitors
    Ackerman, Allison
    Klein, Oliver
    McDermott, David F.
    Wang, Wei
    Ibrahim, Nageatte
    Lawrence, Donald P.
    Gunturi, Anasuya
    Flaherty, Keith T.
    Hodi, F. Stephen
    Kefford, Richard
    Menzies, Alexander M.
    Atkins, Michael B.
    Long, Georgina V.
    Sullivan, Ryan J.
    CANCER, 2014, 120 (11) : 1695 - 1701
  • [29] Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
    Ismail, Rawa K.
    Suijkerbuijk, Karijn P. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Pasmooij, A. M. G.
    van Zeijl, Michiel C. T.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan W. B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Art
    Westgeest, Hans
    van den Eertwegh, Alfons J.
    Wouters, Michel W. J. M.
    MELANOMA RESEARCH, 2022, 32 (06) : 460 - 468
  • [30] Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: Results from the observational study GEM1801
    de Miguel, Pablo Ayala
    Berciano-Guerrero, Miguel-Angel
    Munoz-Couselo, Eva
    Manzano, Jose Luis
    Fuentes, Pablo Cerezuela
    Rivas, Ainara Soria
    Castano, Almudena Garcia
    Crespo, Guillermo
    Puertolas, Teresa
    De La Rosa, Carlos Aguado
    Sanz, Lourdes Gutierrez
    Castro, Rafael Lopez
    Espinosa, Enrique
    Lecumberri, Maria Jose
    Majem, Margarita
    Martinez, Javier Medina
    Bellido, Lorena
    Fernandez, Luis Antonio
    Martin-Algarra, Salvador
    Marquez-Rodas, Ivan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345